RxDoctor Payments Data

James Stackhouse, MD

Ophthalmology · Fernandina, FLNPI 1750517710

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,565 of the $16,793 with a category attached, or 68.9%. 23 manufacturers reported payments, led by Rxsight Inc at 58.9% of the total. 2025 is the largest year on record at $10,239, 3.3 times the $3,061 reported in 2019. Among ophthalmology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,793in general payments, 2019–2025

Across 164 payments — averaging $102.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rxsight Inc$10K
  • Johnson & Johnson Surgical Vision, Inc.$2K
  • Alcon$2K
  • AbbVie$865
  • Glaukos Corporation$743
  • Kala Pharmaceuticals, Inc.$234
  • plus $902 from 17 others

What the payments were for

  • Consulting fees$11,56569%
  • Food & beverage$5,20331%
  • Entertainment$250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,793 in reported general payments places this provider in the 90th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024
$771,967
Medicare patients
883
Services billed
4,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate421$11,758
MoxifloxacinMoxifloxacin Hcl366$8,746
Diclofenac Sodium369$3,622
ValacyclovirValacyclovir Hcl17$671
Latanoprost43$309
Tobramycin20$83
Timolol Maleate11$79
Diazepam16$13

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Fernandina

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →